IDEXX Laboratories Inc. (NASDAQ) on Monday posted fourth-quarter earnings and revenues that beat estimates and issued a bullish initial outlook for 2023.
The Westbroook-based provider of veterinary diagnostics, veterinary practice software and water testing reported earnings of $2.05 per share for the quarter that ended Dec. 31, beating the $1.92 per share consensus estimate of analysts polled by Zacks Investment Research. The figure compares to $1.89 per share for the third quarter of 2022. Read more
